Terms: = Colorectal cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1 AND Staging
4 results:
1. Cytochrome P2E1 (CYP2E1) Gene Polymorphism as a Potential Prognostic Biomarker in colorectal cancer.
Moghadas A; Karbalaie Niya MH; Zamani F; Moazzami M; Farhang F; Ajdarkosh H; Khoonsari M; Faraji A; Panahi M; Emtiazi N; Safarnezhad Tameshkel F; Nikkhah M
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2239-2244. PubMed ID: 37505752
[TBL] [Abstract] [Full Text] [Related]
2. Colon Neuroendocrine Tumors: A New Lymph Node staging Classification.
Fields AC; McCarty JC; Lu P; Vierra BM; Pak LM; Irani J; Goldberg JE; Bleday R; Chan J; Melnitchouk N
Ann Surg Oncol; 2019 Jul; 26(7):2028-2036. PubMed ID: 30927196
[TBL] [Abstract] [Full Text] [Related]
3. The integration of macroscopic tumor invasion of adjacent organs into TNM staging system for colorectal cancer.
Liang JW; Gao P; Wang ZN; Song YX; Xu YY; Wang MX; Dong YL; Xu HM
PLoS One; 2012; 7(12):e52269. PubMed ID: 23300631
[TBL] [Abstract] [Full Text] [Related]
4. Associated primary tumors in patients with gastric cancer.
Dinis-Ribeiro M; Lomba-Viana H; Silva R; Moreira-Dias L; Lomba-Viana R
J Clin Gastroenterol; 2002; 34(5):533-5. PubMed ID: 11960064
[TBL] [Abstract] [Full Text] [Related]
